1. Molecular staging of gynecological cancer: What is the future?
   Pratibha S. Binder et al, 2015, Best Practice & Research Clinical Obstetrics & Gynaecology CrossRef
2. Serum Proteomic Signatures in Cervical Cancer: Current Status and Future Directions
   Chaston Weaver et al, 2024, Cancers CrossRef
3. Epigenetic Mechanisms in Gynecological Cancer
   Gavino Faa et al, 2016, Gynecological Cancers CrossRef
4. Chemotherapy-related leukopenia as a biomarker predicting survival outcomes in locally advanced cervical cancer
   Giorgio Bogani et al, 2017, European Journal of Obstetrics & Gynecology and Reproductive Biology CrossRef
5. The Role of Predictive Biomarkers in Endocervical Adenocarcinoma: Recommendations From the International Society of Gynecological Pathologists
   Tjalling Bosse et al, 2021, International Journal of Gynecological Pathology CrossRef
6. Evaluation of Immunohistochemical Expression of Enhancer of Zeste Homolog 2 (EZH2) and Its Association With Clinicopathological Variables in Carcinoma Cervix
   Aditi Priya et al, 2023, Cureus CrossRef
7. NR2F6 Expression Correlates with Pelvic Lymph Node Metastasis and Poor Prognosis in Early-Stage Cervical Cancer
   Chunhao Niu et al, 2016, International Journal of Molecular Sciences CrossRef
8. Biological implications and therapeutic significance of DNA methylation regulated genes in cervical cancer
   Samatha Bhat et al, 2016, Biochimie CrossRef
9. Growth Differentiation Factor-15 as a Candidate Biomarker in Gynecologic Malignancies: A Meta-analysis
   Dipayan Roy et al, 2022, Cancer Investigation CrossRef
10. Modulation of DNA methylation by human papillomavirus E6 and E7 oncoproteins in cervical cancer (Review)
    Prakriti Sen et al, 2017, Oncology Letters CrossRef
11. Human Papillomaviruses-Associated Cancers: An Update of Current Knowledge
    Ena Pešut et al, 2021, Viruses CrossRef
12. Exploring the utility of FTS as a bonafide binding partner for EGFR: A potential drug target for cervical cancer
    Sneha Krishnamoorthy et al, 2023, Computers in Biology and Medicine CrossRef
13. Nuclear Expression of GS28 Protein: A Novel Biomarker that Predicts Worse Prognosis in Cervical Cancers
    Uiju Cho et al, 2016, PLOS ONE CrossRef
14. Exploration of biomarkers for the diagnosis, treatment and prognosis of cervical cancer: a review
    Masita Arip et al, 2022, Discover Oncology CrossRef
15. CD105 (endoglin) expression as a prognostic marker of angiogenesis in squamous cell cervical cancer treated with radical radiotherapy
    Evrim Metcalfe et al, 2018, Journal of Cancer Research and Therapeutics CrossRef
16. Levels of Folate and Vitamin B12, and Genetic Polymorphisms Involved in One-Carbon Metabolism May Increase the Risk of Cervical Cytological Abnormalities
    Nayara Nascimento Toledo Silva et al, 2022, Nutrition and Cancer CrossRef
17. Integrative analysis of DNA methylation and gene expression identified cervical cancer-specific diagnostic biomarkers
    Wanxue Xu et al, 2019, Signal Transduction and Targeted Therapy CrossRef
18. B3GNT3 Expression Is a Novel Marker Correlated with Pelvic Lymph Node Metastasis and Poor Clinical Outcome in Early-Stage Cervical Cancer
    Weijing Zhang et al, 2015, PLOS ONE CrossRef
19. The future role of molecular staging in gynecologic cancer
    Pratibha S. Binder et al, 2015, International Journal of Gynecology & Obstetrics CrossRef
20. 3’UTR polymorphism of Thymidylate Synthase gene increased the risk of persistence of pre-neoplastic cervical lesions
    Nayara Nascimento Toledo Silva et al, 2020, BMC Cancer CrossRef